Overview
- Description
Xeltis BV is a clinical–stage, medical device company, pioneering a restorative approach in cardiovascular therapy. The company has developed a polymer-based suite of restorative cardiovascular devices - implants that trigger patient’s body to regenerate living and long-lasting valves or vessels, made by patient’s own tissues. The breakthrough technology of regenerative blood vessels is based on Endogenous Tissue Restoration, the Nobel-prize awarded scientific developments of Professor Jean-Marie Lehn, currently a member of Xeltis’ Scientific Advisory Board.
- Website
- Founded
2006
- Project
- Country
- The Netherlands
- Theme
- Healthcare